Crossmark

Inclusion and exclusion criteria used in non-specific low back pain trials: a review of randomised controlled trials published between 2006 and 2012

Crossref DOI link: https://doi.org/10.1186/s12891-018-2034-6

Published Online: 2018-04-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Amundsen, Pål André https://orcid.org/0000-0003-0959-4725
Evans, David W.

Rajendran, Dévan

Bright, Philip

Bjørkli, Tom

Eldridge, Sandra

Buchbinder, Rachelle

Underwood, Martin

Froud, Robert
License Information

Text and Data Mining valid from 2018-04-12
More Information

Article History

Received: 12 January 2018

Accepted: 4 April 2018

First Online: 12 April 2018

Ethics approval and consent to participate

: Not applicable.

: PA, TB, PB, DR, DE, RB, and SE declare that they have no competing interests. MU is co-author on multiple trials of treatments for nsLBP some of which are included in this review. He has received multiple research grants from NIHR and ARUK as chief or co-investigator, he is an editor for NIHR journal series for which he receives a fee. MU and RF are directors and shareholders of Clinvivo Ltd., a University of Warwick spin-out company.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.